Literature DB >> 10535309

The Plasmodium falciparum translationally controlled tumor protein: subcellular localization and calcium binding.

J Bhisutthibhan1, M A Philbert, H Fujioka, M Aikawa, S R Meshnick.   

Abstract

Artemisinin derivatives are endoperoxide antimalarials widely used to treat falciparum malaria in areas where drug resistance is common. In Plasmodium falciparum-infected erythrocytes, radiolabeled artemisinin derivatives have been shown to react with malarial proteins, one of which is the Translationally Controlled Tumor Protein (TCTP). The P. falciparum TCTP was found by immunofluorescence to be located in both the cytoplasm and food vacuoles. Immunoelectron microscopy shows that it is present in the parasite cytoplasm as well as in its food vacuolar and limiting membranes. Like other TCTPs, the P. falciparum protein binds to calcium. Further studies on the physiological role of TCTP may aid in understanding the mechanism of action of endoperoxide antimalarials.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10535309     DOI: 10.1016/S0171-9335(99)80052-1

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  13 in total

1.  Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii.

Authors:  D J Walker; J L Pitsch; M M Peng; B L Robinson; W Peters; J Bhisutthibhan; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Heat-inducible translationally controlled tumor protein of Trichinella pseudospiralis: cloning and regulation of gene expression.

Authors:  C H Mak; M W Poon; H M Lun; P Y Kwok; R C Ko
Journal:  Parasitol Res       Date:  2006-12-06       Impact factor: 2.289

3.  The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR.

Authors:  Ulrich-Axel Bommer; Anton V Borovjagin; Martin A Greagg; Ian W Jeffrey; Paul Russell; Kenneth G Laing; Melanie Lee; Michael J Clemens
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

4.  Immunoprecipitation of [(3)H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies.

Authors:  J Bhisutthibhan; S R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

Review 5.  Fortilin: A Potential Target for the Prevention and Treatment of Human Diseases.

Authors:  Decha Pinkaew; Ken Fujise
Journal:  Adv Clin Chem       Date:  2017-08-07       Impact factor: 5.394

6.  Immune mimicry in malaria: Plasmodium falciparum secretes a functional histamine-releasing factor homolog in vitro and in vivo.

Authors:  S M MacDonald; J Bhisutthibhan; T A Shapiro; S J Rogerson; T E Taylor; M Tembo; J M Langdon; S R Meshnick
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

7.  Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies.

Authors:  Maranda S Cantrell; Jackson D Wall; Xinzhu Pu; Matthew Turner; Luke Woodbury; Ken Fujise; Owen M McDougal; Lisa R Warner
Journal:  Protein Expr Purif       Date:  2021-10-06       Impact factor: 1.650

Review 8.  Discovery, mechanisms of action and combination therapy of artemisinin.

Authors:  Liwang Cui; Xin-zhuan Su
Journal:  Expert Rev Anti Infect Ther       Date:  2009-10       Impact factor: 5.091

9.  Sumoylation of human translationally controlled tumor protein is important for its nuclear transport.

Authors:  Gnanasekar Munirathinam; Kalyanasundaram Ramaswamy
Journal:  Biochem Res Int       Date:  2012-04-11

10.  An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum.

Authors:  Geoffrey H Siwo; Roger S Smith; Asako Tan; Katrina A Button-Simons; Lisa A Checkley; Michael T Ferdig
Journal:  BMC Genomics       Date:  2015-12-04       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.